Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 8/2018

Open Access 01-08-2018 | Case-Based Update

Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update

Authors: F. Sharouf, M. Zaben, A. Lammie, P. Leach, M. I. Bhatti

Published in: Child's Nervous System | Issue 8/2018

Login to get access

Abstract

Introduction

Neurocutaneous melanosis (NCM) is a sporadic condition characterised by congenital melanocytic nevi and melanocytic thickening of the leptomeninges. It is believed to result from congenital dysplasia of melanin-producing cells within the skin and leptomeninges. The management of cutaneous manifestations remains controversial; for neurological manifestations, outcome remains poor even with the use of radiotherapy and chemotherapy.

Patients and methods

We describe the case of a 5-month-old boy who presented with giant congenital melanocytic nevus and hydrocephalus. MR imaging and CSF immunohistochemistry confirmed leptomeningeal melanosis. We discuss the diagnosis, treatment and prognosis of this rare disorder in the light of recent published literature.

Results

Patient required placement of right-sided ventriculoperitoneal shunt to control hydrocephalus. The patient tolerated the procedure well and was discharged home with normal neurological function. A presumptive diagnosis of NCM was made based on the MR characteristics, CSF cytology and clinical presentation. He received trametinib, a MAPK/Erk kinase inhibitor for 7 months. At 30 months of age, he developed left-sided weakness and status epilepticus requiring paediatric intensive care unit admission and ventilator support. The patient eventually succumbed to malignant transformation of leptomeningeal disease.

Conclusion

Cutaneous manifestations of NCM are usually congenital, and neurological manifestations develop early in life. Patients with large or multiple congenital nevi should therefore be investigated early to facilitate treatment. MR imaging is the investigation of choice which can further assist in performing biopsy. Symptomatic NCM is refractory to radiotherapy and chemotherapy and has a poor prognosis. A multidisciplinary approach is necessary in the management of NCM patients.
Literature
1.
2.
Allcutt D, Michowiz S, Weitzman S, Becker L, Blaser S, Hoffman HJ, Humphreys RP, Drake JM, Rutka JT (1993) Primary leptomeningeal melanoma: an unusually aggressive tumor in childhood. Neurosurgery 32:721–729 [discussion: 729]CrossRefPubMed
3.
Arai M, Nosaka K, Kashihara K, Kaizaki Y (2004) Neurocutaneous melanosis associated with Dandy–Walker malformation and a meningohydroencephalocele. J Neurosurg 100(Pediatrics 5):501–505PubMed
4.
Barkovich AJ, Frieden IJ, Williams ML (1994) MR of neurocutaneous melanosis. AJNR Am J Neuroradiol 15:859–867PubMed
5.
Chaloupka JC, Wolf RJ, Varma PK (1996) Neurocutaneous melanosis with the Dandy-Walker malformation: a possible rare pathoetiologic association. Neuroradiology 38:486–489CrossRefPubMed
6.
7.
Chu WCW, Lee V, Chan Y, Shing MMK, Chik K, Li C, Ma K (2003) Neurocutaneous melanomatosis with rapidly deteriorating course. AJNR Am J Neuroradiol 24:287–290PubMed
8.
de Andrade DO, Dravet C, Raybaud C, Broglin D, Laguitton V, Girard N (2004) An unusual case of neurocutaneous melanosis. Epileptic Disorders 6:145–152PubMed
9.
de Wijn RS, Zaal LH, Hennekam RC et al (2010) Familial clustering of giant congenital melanocytic nevi. J Plast Reconstr Aesthet Surg 63:906–913CrossRefPubMed
10.
Demirci A, Kawamura Y, Sze G, Duncan C (1995) MR of parenchymal neurocutaneous melanosis. AJNR Am J Neuroradiol 16:603–606PubMed
11.
Di Rocco F, Sabatino G, Koutzoglou M, Battaglia D, Caldarelli M, Tamburrini G (2004) Neurocutaneous melanosis. Childs Nerv Syst 20:23–28CrossRefPubMed
12.
Fox H (1972) Neurocutaneous melanosis. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology. Elsevier, New York, pp 414–428
13.
Frieden IJ, Williams ML (1994) Familial site-specific congenital melanocytic nevus: report of two families. Arch Dermatol 130:1075–16FfCrossRefPubMed
14.
Frieden IJ, Williams ML, Barkovich AJ (1994) Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children. J Am Acad Dermatol 31:423–429CrossRefPubMed
15.
16.
Hsueh CW, Ho CS, Chiu NC, Shen EY (2004) Neurocutaneous melanosis with hydrocephalus: report of one case. Acta Neurol Taiwanica 13:29–33
17.
18.
19.
Kadonaga N, Barkovich JA, Edwards MSB, Frieden IJ (1992) Neurocutaneous melanosis in association with the Dandy Walker complex. Pediatr Dermatol 9:37–43CrossRefPubMed
20.
Kadonaga N, Frieden J (1991) Neurocutaneous melanosis. Definition and review of the literature. J Am Acad Dermatol 24:747–755CrossRefPubMed
21.
Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, v Chalker J, McKenzie K, Abu-Amero S, Slater O, Chanudet E, Palmer R, Morrogh D, Stanier P, Healy E, Sebire NJ, Moore GE (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133:2229–2236CrossRefPubMedPubMedCentral
22.
Ko SF, Wang HS, Lui TN, Ng SH, Ho YS, Tsai CC (1993) Neurocutaneous melanosis associated with inferior vermian hypoplasia: MR findings. J Comput Assist Tomogr 17:691–695CrossRefPubMed
23.
Makin GW, Eden OB, Lashford LS, Moppett J, Gerrard MP, Davies HA, Powell CV, Campbell AN, Frances H (1999) Leptomeningeal melanoma in childhood. Cancer 86:878–886CrossRefPubMed
24.
Marnet D, Vinchon M, Mosto K, Catteau B, Kerdraon O, Dhellemmes P (2009) Neurocutaneous melanosis and the Dandy-Walker complex: an uncommon but not so insignificant association. Childs Nerv Syst 25:1533–1539CrossRefPubMed
25.
McClelland S 3rd, Charnas LR, SantaCruz KS, Garner HP, Lam CH (2007) Progressive brainstem compression in an infant with neurocutaneous melanosis and Dandy–Walker complex following ventriculoperitoneal shunt placement for hydrocephalus. J Neurosurg 107(6 Suppl Pediatrics):500–503PubMed
26.
Mena-Cedillos CA, Valencia-Herrera AM, Arroyo-Pineda AI, Salgado-Jimenez MA, Espinoza-Montero R, Martinez-Avalos AB, Perales-Arroyo A (2002) Neurocutaneous melanosis in association with the Dandy Walker complex complicated by melanoma. Pediatr Dermatol 19:237–242CrossRefPubMed
27.
28.
Pavlidou E, Hagel C, Papavasilliou A, Giouroukos S, Panteliadis C (2008) Neurocutaneous melanosis: report of three cases and up-to-date review. J Child Neurol 23:1382–1391CrossRefPubMed
29.
Peters R, Jansen G, Engelbrecht V (2000) Neurocutaneous melanosis with hydrocephalus, intraspinal arachnoid collections and syringomyelia: case report and literature review. Pediatr Radiol 30:284–288CrossRefPubMed
30.
Rhodes RE, Friedman HS, Hutten HP, Hockenberger D, Oakes WJ, Tomita T (1991) Contrast enhancement MR imaging of neurocutaneous melanosis. AJNR Am J Neuroradiol 12:380–382PubMed
31.
Rokitansky J (1861) Ein ausgezeichneter Fall von Pigment-Mal mit ausgebreiteter Pigmentierung der inneren Hirn- und Rckenmarkshute. Allgem Wien Med Z 6:113–116
32.
Sebag G, Dubois J, Pfister P, Brunelle F, Saint-Rose C (1991) Neurocutaneous melanosis and temporal lobe tumor in a child: MR study. AJNR Am J Neuroradiol 12:380–382
33.
Shinno K, Nagahiro S, Uno M, Kannuki S, Nakaiso M, Sano N, Horiguchi H (2003) Neurocutaneous melanosis associated with malignant leptomeningeal melanoma in an adult: clinical significance of 5-S-cysteinyldopa in the cerebrospinal fluid—case report. Neurol Med Chir (Tokyo) 43(12):619–625CrossRef
34.
Sung KS, Song YJ (2014) Neurocutaneous melanosis in association with Dandy-Walker complex with extensive intracerebral and spinal cord involvement. J Korean Neurosurg Soc 56(1):61–65CrossRefPubMedPubMedCentral
35.
Swar MO, Mahgoub SM, Yassin RO, Osman AM (2013) Dandy-Walker malformation and neurocutaneous melanosis in a three-month-old infant. Sudanese J Paediatr 13(2):61–65
36.
37.
Takayama H, Nagashima Y, Hara M, Takagi H, Mori M, Merlino G, Nakazato Y (2001) Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis. J Am Acad Dermatol 44:538–540CrossRefPubMed
38.
Van Bogaert L (1948) La melanose neurocutanee diffuse heredofamiliale. Bull Acad R Belg 13:397–428
39.
40.
41.
Metadata
Title
Neurocutaneous melanosis presenting with hydrocephalus and malignant transformation: case-based update
Authors
F. Sharouf
M. Zaben
A. Lammie
P. Leach
M. I. Bhatti
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 8/2018
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-018-3851-5

Other articles of this Issue 8/2018

Child's Nervous System 8/2018 Go to the issue

Review Paper

Gunshot penetrating brain injury in children: report of three cases with review of the literature

Original Paper

Distinct demographic profile and molecular markers of primary CNS tumor in 1873 adolescent and young adult patient population

Case Report

Intrinsic epidermoid of the brain stem: case report and review of the literature

Original Paper

Prenatal diagnosis of Apert syndrome using ultrasound, magnetic resonance imaging, and three-dimensional virtual/physical models: three case series and literature review

Case Report

Intracranial malignant peripheral nerve sheath tumor variant: an unusual neurovascular phenotype sarcoma case invading through the petrous bone

Letter to the Editor

Spontaneous bone formation in a large craniectomy defect